LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.30
+0.24 (3.40%)
Aug 3, 2026, 12:04 PM EDT - Market open
LeonaBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.83 | 69.28 | 48.44 | 90.58 | 95.97 | 110.54 |
Short-Term Investments | 34.85 | 19.06 | 2.84 | 56.84 | 104.38 | 143.22 |
Cash & Short-Term Investments | 67.68 | 88.33 | 51.28 | 147.42 | 200.34 | 253.76 |
Cash Growth | 84.56% | 72.27% | -65.22% | -26.42% | -21.05% | 37.40% |
Other Receivables | - | - | - | 1.63 | 1.23 | 2.34 |
Total Trade Receivables | - | - | - | 1.63 | 1.23 | 2.34 |
Other Current Assets | 1.52 | 1.13 | 3.57 | 5.68 | 5.96 | 4.7 |
Total Current Assets | 69.2 | 89.46 | 54.84 | 154.73 | 207.53 | 260.8 |
Net Property, Plant & Equipment | 1.7 | 2.01 | 3.25 | 4.44 | 5.32 | 5.22 |
Long-Term Investments | - | - | - | - | 44.83 | 65.94 |
Other Long-Term Assets | 0.69 | 0.69 | 0.69 | 1.08 | 0.48 | 0.06 |
Total Assets | 71.59 | 92.15 | 58.78 | 160.25 | 258.15 | 332.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.76 | 4.59 | 0.32 | 0.13 | 2.5 | 0.57 |
Accrued Expenses | 4.42 | 4.96 | 12.4 | 28.34 | 18.6 | 8.44 |
Current Portion of Leases | 0.48 | 0.47 | 0.41 | 0.37 | 0.33 | 0.29 |
Total Current Liabilities | 6.67 | 47.5 | 13.14 | 28.84 | 21.43 | 9.29 |
Long-Term Leases | 0.21 | 0.34 | 0.8 | 1.22 | 1.59 | 1.63 |
Other Long-Term Liabilities | 15.41 | 16.52 | - | - | - | - |
Total Long-Term Liabilities | 15.62 | 16.86 | 0.8 | 1.22 | 1.59 | 1.63 |
Total Liabilities | 22.29 | 64.36 | 13.94 | 30.06 | 23.02 | 10.92 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | - | 0 | 0 | 0 |
Additional Paid-in Capital | 594.02 | 539.55 | 450.99 | 439.74 | 428.62 | 417.36 |
Accumulated Other Comprehensive Income | -0.01 | -0 | 0 | -0.35 | -1.96 | -0.39 |
Retained Earnings | -544.7 | -511.76 | -406.15 | -309.21 | -191.53 | -95.9 |
Total Common Shareholders' Equity | 49.3 | 27.79 | 44.84 | 130.19 | 235.14 | 321.08 |
Minority Interest | - | 37.49 | - | - | - | - |
Shareholders' Equity | 49.3 | 65.28 | 44.84 | 130.19 | 235.14 | 321.08 |
Total Liabilities & Equity | 71.59 | 92.15 | 58.78 | 160.25 | 258.15 | 332.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.69 | 0.8 | 1.22 | 1.59 | 1.91 | 1.92 |
Net Cash (Debt) | 66.99 | 87.53 | 50.06 | 145.83 | 198.43 | 251.84 |
Net Cash Growth | 88.42% | 74.85% | -65.67% | -26.51% | -21.21% | 37.11% |
Net Cash Per Share | 8.31 | 20.47 | 13.01 | 38.36 | 52.59 | 68.21 |
Book Value | 49.3 | 27.79 | 44.84 | 130.19 | 235.14 | 321.08 |
Book Value Per Share | 6.12 | 6.50 | 11.65 | 34.24 | 62.32 | 86.96 |
Tangible Book Value | 49.3 | 27.79 | 44.84 | 130.19 | 235.14 | 321.08 |
Tangible Book Value Per Share | 6.12 | 6.50 | 11.65 | 34.24 | 62.32 | 86.96 |